Bromantane administration in therapeutic doses is characterised from the Just about full absence of side effects such as manifestations of withdrawal syndrome and hyperstimulation (Morozov et alEthomersol reveals properties of the central action vasodilator in blocking the potential-dependent and particularly the receptor-dependent calcium channels